Updated:
Hangzhou Tigermed Consulting Company Limited
Hangzhou Tigermed Consulting Company Limited is a CRO with over 11,000 employees servicing pharmaceutical and medical device clients across 180+ countries.
Hangzhou Tigermed Consulting Company Limited
Tigermed operates as a contract research organization (CRO) headquartered in Hangzhou, China, with additional offices in Shanghai and Hong Kong. The firm was founded in the 2000s (exact year not disclosed) and is led by management whose names are not publicly listed on the company website. Its core business is providing outsourced research services to pharmaceutical and medical device companies. The firm's service suite covers preclinical development, clinical development, manufacturing services, analytical services, and real-world study design. Tigermed claims over 11,000 employees and reports serving more than 4,000 clients across 180+ countries (per the firm's website). It positions itself as a full-service CRO with end-to-end capabilities, from early-stage research through regulatory affairs. The company does not disclose investment strategy or portfolio holdings, as its model is service-based rather than capital-deployment. Tigermed reports 11,000+ professionals and a reach of 180+ countries and 170+ therapeutic areas (per the firm). The firm maintains operational offices in Hangzhou, Shanghai, and Hong Kong. No recent operational events were available from the firm's website or public record that meet the 24-month threshold for inclusion. Tigermed's structural differentiator is its scale as a large Chinese-headquartered CRO with a global footprint, employing over 11,000 people across 180+ countries. This contrasts with smaller, regionally focused CROs. The firm does not appear to operate as an investment vehicle, family office, or asset manager; its model is fee-for-service clinical research.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Hangzhou
Corporate office
Hangzhou, Shanghai, Hong Kong, China
Additional offices
Shanghai, China · Hong Kong, China
Sector focus
Frequently asked questions
Does Tigermed operate as a family office or investment firm?
No. Tigermed is a contract research organization (CRO) that provides fee-for-service clinical research and development support to pharmaceutical and medical device companies. It does not function as a family office, asset manager, or investment vehicle. Its business model is service-based rather than capital-deployment.
What services does Tigermed offer?
Tigermed offers a full suite of CRO services including preclinical development, clinical development, manufacturing services, analytical services, and real-world study design. The firm presents these as an integrated platform with end-to-end capabilities across the drug development lifecycle.
How many employees does Tigermed have?
Tigermed reports over 11,000 employees on its website. The firm also claims to have served over 4,000 clients and operates across 180+ countries and 170+ therapeutic areas (per the firm's website).
Where is Tigermed headquartered and what is its geographic focus?
Tigermed is headquartered in Hangzhou, China, with additional offices in Shanghai and Hong Kong. The firm states it operates globally across 180+ countries, indicating a broad international reach for clinical trial services.
Is Tigermed publicly listed or privately held?
The firm's website does not explicitly state its ownership structure. Hangzhou Tigermed Consulting Company Limited is the corporate entity name used, but no public listing or private ownership details are confirmed in the available sources.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: